Literature DB >> 3496271

Heterogeneity in the activation requirements of T cells stimulated by phytohaemagglutinin.

H S Warren, A Bezos.   

Abstract

Data are presented showing that resting T cells proliferated in response to phytohaemagglutinin (PHA) provided that either sheep erythrocytes (SRC) or interleukin-2(IL-2) was added. Proliferation requiring PHA and SRC was inhibited by anti-CD2 monoclonal antibody (OKT11) and anti-CD3 monoclonal antibody (OKT3). These monoclonal antibodies only partially inhibited IL-2 production stimulated by PHA and SRC, and added IL-2 did not restore proliferation in these cultures. Low concentrations of cyclosporine inhibited both proliferation and IL-2 production (ED50 = 12 and 9 ng/ml, respectively) and this inhibition was partially relieved in the presence of added IL-2 (ED50 = 110 ng/ml). In contrast, proliferation stimulated by PHA with exogenous IL-2 was not inhibited in the presence of OKT11, and moderate concentrations of cyclosporine were required to inhibit proliferation (ED50 = 49 ng/ml). Evidence was obtained, from analysis of cultures at limiting dilution, to suggest that the different requirements for stimulation of PHA-responsive T cells reflected different T-cell subpopulations. The majority of PHA-responsive cells proliferated in the presence of PHA and SRC, whereas only a minority proliferated in the presence of PHA and exogenous IL-2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496271      PMCID: PMC1453391     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations.

Authors:  D A Fox; R E Hussey; K A Fitzgerald; A Bensussan; J F Daley; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

2.  Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor.

Authors:  K O'Flynn; A M Krensky; P C Beverley; S J Burakoff; D C Linch
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

3.  Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine.

Authors:  H S Warren
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

4.  Is the E receptor on human T lymphocytes a "negative signal receptor"?

Authors:  R Palacios; O Martinez-Maza
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  A method for the production and quantitative assay of human lymphokine preparations.

Authors:  H S Warren; R G Pembrey
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.

Authors:  W Tadmori; J C Reed; P C Nowell; M Kamoun
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes.

Authors:  J C Reed; W Tadmori; M Kamoun; G Koretzky; P C Nowell
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Role of the E receptor in interferon-gamma expression: sheep erythrocytes augment interferon-gamma production by human lymphocytes.

Authors:  M Wilkinson; A G Morris
Journal:  Cell Immunol       Date:  1984-06       Impact factor: 4.868

9.  Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.

Authors:  G Kruger; K Welte; N Ciobanu; C Cunningham-Rundles; P Ralph; S Venuta; S Feldman; B Koziner; C Y Wang; M A Moore
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

10.  Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2.

Authors:  H S Warren; K Atkinson; R G Pembrey; J C Biggs
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

View more
  4 in total

1.  Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells.

Authors:  H S Warren; L J Skipsey
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

2.  Cytokine expression by high-density human lymphocytes.

Authors:  W A Sewell; M F Berger; L J Skipsey; M A Cooley; H S Warren
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  The T11(3) epitope of the CD2 molecule, sheep erythrocytes, and the alternative T-cell activation pathway.

Authors:  H S Warren; V McPhun; A Bezos; C R Parish
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

4.  Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation.

Authors:  H S Warren; L J Skipsey
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.